Bimodal neuromodulation (Lenire): does it help with tinnitus?

In recent years, one term has been appearing more and more frequently among those seeking solutions for tinnitus: bimodal neuromodulation. Behind the technical term lies a simple idea and one of the most solid pieces of evidence in recent research.

How it works: two stimuli, one brain to retrain

Bimodal neuromodulation combines two synchronised signals: sounds through headphones and gentle electrical pulses from a small device placed on the tongue. Presented together, in a coordinated way, they push the brain to reorganise the overactive auditory circuits at the root of the ringing. It is guided "retraining", not masking.

What studies show

In the study published in Science Translational Medicine (Conlon, 2020), in 326 people the therapy produced a noticeable reduction in tinnitus distress, with 80.1% of participants maintaining the improvement at 12 months after completion. The subsequent study (Conlon, 2022) confirmed reductions of up to 20 THI points, with 91% lasting improvement. These are significant numbers for a field where few things genuinely work.

What it is NOT

Bimodal neuromodulation is a medical device (the best known is called Lenire), used with a defined protocol and ideally under the guidance of an audiologist. It is not an app, not a toy and not suitable for everyone. It should be treated as a clinical option, to be evaluated with a specialist, not a purchase to make on your own.

Where it sits relative to other approaches

For most people, the path starts with accessible foundations: sound therapy, sleep habits, stress management, cognitive exercises. Bimodal neuromodulation is a more specialised tool, useful when distress is significant and a targeted intervention is sought. An app like AURALIS works on the other side: daily sound, calm and consistency.

In short

Bimodal neuromodulation "retrains" the brain with sound and micro-pulses on the tongue, and in the most extensive studies it reduces tinnitus distress with lasting results. It is the most promising approach of recent years, but it remains a medical device used under specialist guidance — an option, not a universal promise.